GlaxoSmithKline yesterday reported a drop of £125 million (HK$1.57 billion) in mainland sales last year, prompting the British drug giant to talk up its investments in India without mentioning expansion plans in China.
via Business feed http://ift.tt/1cVKe0F
Labels: Business, China, Hong Kong